factor vii
SpainDrugs containing this active substance
-
It is used to prevent bleeding during surgery or to treat hemorrhages caused by a deficiency of certain coagulation factors in the blood (factors II, VII, IX, and X).
Form: powder and solvent for solution for injection
Active substance Dosage factor ii 800-1920 UI factor vii 400-1000 UI factor ix 800-1240 UI factor x 880-2400 UI protein c 600-1800 UI protein s 480-1520 UI Manufacturer: Csl Behring Gmbh
-
It is used to prevent and treat bleeding caused by a lack of certain coagulation factors (II, VII, IX, and X) in the blood, whether due to a congenital or acquired deficiency, provided that specific products for each factor are not available.
Form: powder and solvent for solution for injection
Active substance Dosage factor ii 400-960 UI factor vii 200-500 UI factor ix 400-620 UI factor x 440-1200 UI protein c 300-900 UI protein s 260-520 UI Manufacturer: Csl Behring Gmbh
-
It is used to treat and prevent bleeding caused by vitamin K antagonists (such as warfarin) when rapid correction of the deficiency is required. It is also used in individuals born with a deficiency of coagulation factors II and X, when a specific purified coagulation factor product is not available.
Form: powder and solvent for solution for infusion
Active substance Dosage factor ii 14-38 UI factor vii 9-24 UI factor ix 25 UI factor x 18-30 UI protein c 13-31 UI protein s 12-32 UI Manufacturer: Octapharma S.A.
-
It is used to treat and prevent bleeding caused by vitamin K antagonists (such as warfarin) when rapid correction of coagulation deficiency is required. It is also used in individuals born with a deficiency of coagulation factors II and X, when a specific purified product is not available.
Form: powder and solvent for solution for infusion
Active substance Dosage factor ii 11-38 UI factor vii 9-24 UI factor ix 25 UI factor x 18-30 UI plasma proteins 7-31 UI plasma proteins 7-32 UI Manufacturer: Octapharma S.A.
-
It is used to treat hemorrhages, prevent bleeding before or after surgery, and to treat coagulation factor deficiency, whether due to congenital (from birth) or acquired causes.
Form: powder and solvent for solution for injection
Active substance Dosage factor ii 375 - 708 UI factor vii 417 UI factor ix 500 UI factor x 500 UI human protein c ≥ 333 UI Manufacturer: Baxalta Innovations Gmbh
-
It is used to treat hemorrhages, prevent bleeding before or after surgery, and to treat coagulation factor deficiency (whether acquired due to medication or congenital).
Form: powder and solvent for solution for injection
Active substance Dosage factor ii 480-900 UI factor vii 500 UI factor ix 600 UI factor x 600 UI protein c MIN 400 UI Manufacturer: Baxalta Innovations Gmbh